IRIDEX CFO Sells $16,480 in Stock (IRIX)
IRIDEX (NASDAQ:IRIX) CFO James H. Mackaness unloaded 2,000 shares of IRIDEX stock on the open market in a transaction that occurred on Monday, June 23rd. The shares were sold at an average price of $8.24, for a total transaction of $16,480.00. Following the completion of the transaction, the chief financial officer now directly owns 2,000 shares in the company, valued at approximately $16,480. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of IRIDEX (NASDAQ:IRIX) remained flat at $8.31 during during mid-day trading trading on Tuesday. The stock had a trading volume of 8,189 shares. IRIDEX has a 52 week low of $5.30 and a 52 week high of $11.00. The stock has a 50-day moving average of $8.53 and a 200-day moving average of $8.9. The company has a market cap of $82.7 million and a price-to-earnings ratio of 45.66.
IRIDEX (NASDAQ:IRIX) last released its earnings data on Thursday, May 1st. The company reported $0.05 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.06 by $0.01. The company had revenue of $10.30 million for the quarter, compared to the consensus estimate of $8.90 million. On average, analysts predict that IRIDEX will post $0.20 earnings per share for the current fiscal year.
IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.